SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-24-010149
Filing Date
2024-05-14
Accepted
2024-05-14 15:15:08
Documents
12
Period of Report
2024-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4825
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 2238
3 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 160496
4 GRAPHIC exhibit99-1xu002.jpg GRAPHIC 153197
5 GRAPHIC exhibit99-1xu003.jpg GRAPHIC 202381
6 GRAPHIC exhibit99-1xu004.jpg GRAPHIC 190943
7 GRAPHIC exhibit99-1xu005.jpg GRAPHIC 105910
8 GRAPHIC exhibit99-1xu006.jpg GRAPHIC 173832
9 GRAPHIC exhibit99-1xu007.jpg GRAPHIC 173175
10 GRAPHIC exhibit99-1xu008.jpg GRAPHIC 235797
11 GRAPHIC exhibit99-1xu009.jpg GRAPHIC 192170
12 GRAPHIC exhibit99-1xu011.jpg GRAPHIC 57908
  Complete submission text file 0001062993-24-010149.txt   2275967
Mailing Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9
Business Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 24943703
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)